Latest update on The TIES Solution
In today’s Europe of stricter safety and regulatory protocols, we are committed to do whatever it takes to bring the lifestyle changing TIES solution to as many people as possible”.
Archives
Read more 
New Stockholm office
OstomyCure has moved its Stockholm operations from Kista to the Karolinska Campus area in Solna in the heart of the bustling Stockholm life science scene.
Read more
First Patients enrolled in the C03 clinical study in the UK
Today, the first patient was enrolled in the TIES03 study of the Ostom Cure Transcuteous Implant Evacuation System (TIES®). A 64-year-old female from the UK had the TIES port successfully implanted in a procedure that took less than an hour with no complications. “We see the TIES® Solution as a potential step change for ileostomy patients, providing them with a better quality of life,” said Prof. David Jayne,
Read more
OstomyCure AS receives sought-after Horizon 2020 EU grant of € 2.5 Mio.
OstomyCure AS has received a EU grant of € 2.5 Mio. via the Horizon 2020 Project.(https://ec.europa.eu/programmes/horizon2020/what-horizon-2020). “This EU grant is a major milestone for OstomyCure AS, and further confirms the very unique benefits of TIES Solution which are now endorsed by a very capable public institution” – Says Dr. Ben Broennimann, CEO of OstomyCure AS
Read moreLarge clinical study started in UK and Sweden
Significant Achievement for OstomyCure AS and TIES® Solution Approval for multicenter study “TIES-C03” in major university hospitals in Leeds, UK & Umeå, Sweden. OstomyCure AS has achieved an important milestone on the way to making the revolutionary TIES® Solution available to ileostomy patients, a patient population that has not experienced any meaningful improvements in “standard
Read more
Latest update on TIES Solution
Website news release Latest update on TIES Solution – January 2018 Message from CEO Ostomycure Dr Benedict Broenniman M.D. In consultation with our Notified Body, it has been decided to collect additional clinical data in a new clinical study at specialized colorectal units in the UK & Sweden. The previous sponsored studies have shown the
Read more
OstomyCure AS Appoints new Chief Medical Officer
Read more“We are delighted to have Dr. Wong join our team,” said Dr. Benedict Broennimann, Chief Executive Officer of OstomyCure.“
Article in IA Journal: Issue 233 Autumn 2016
OstomyCure AS has been published in The Ileostomy & Internal Pouch Support Groups latest issue of the IA Journal. http://ostomycure.wpengine.com/wp-content/uploads/2016/08/ties-article-in-ia-journal-no233-2016.pdf
Read more
Experienced Chief Commercial Officer Joins OstomyCure AS
PRESS RELEASE, FOR IMMEDIATE RELEASE September 26, 2016, OSLO Experienced Chief Commercial Officer Joins OstomyCure AS OstomyCure AS engages Morten Gunvad, currently founder and Head of GP Consulting GmbH, as Chief Commercial Officer of the TIES® System. The Norwegian medical device company OstomyCure AS reinforces its organization and is pleased to announce the former Covidien
Read more
The TIES® System represented at major political event
The TIES® Implant and Lid will be represented at Almedalsveckan, an annual political event taking place in Visby, Sweden. https://ostomycure.com/sites/default/files/poster5_swerea_implantat_ok.pdf
Read more
Photostream
© 2022 OstomyCure. All rights reserved | Web by RIIoT Digital